Goldman Sachs’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-100
Closed -$5K 7007
2017
Q1
$5K Buy
+100
New +$4.87K ﹤0.01% 6658
2016
Q3
Sell
-100
Closed -$4K 7217
2016
Q2
$4K Hold
100
﹤0.01% 6947
2016
Q1
$4K Sell
100
-3,000
-97% -$110K ﹤0.01% 6997
2015
Q4
$113K Buy
3,100
+1,200
+63% +$43.4K ﹤0.01% 6103
2015
Q3
$62K Buy
1,900
+1,400
+280% +$47.1K ﹤0.01% 6708
2015
Q2
$19K Sell
500
-2,100
-81% -$76.4K ﹤0.01% 7086
2015
Q1
$91K Sell
2,600
-2,600
-50% -$91.7K ﹤0.01% 6461
2014
Q4
$198K Buy
5,200
+2,700
+108% +$98.8K ﹤0.01% 6163
2014
Q3
$89K Buy
2,500
+1,200
+92% +$44.6K ﹤0.01% 6629
2014
Q2
$51K Buy
1,300
+500
+63% +$18.7K ﹤0.01% 6762
2014
Q1
$29K Sell
800
-4,400
-85% -$160K ﹤0.01% 6651
2013
Q4
$180K Sell
5,200
-4,700
-47% -$151K ﹤0.01% 6016
2013
Q3
$277K Buy
9,900
+2,100
+27% +$56K ﹤0.01% 5618
2013
Q2
$210K Buy
+7,800
New +$215K ﹤0.01% 5556

Other funds holding XYL

Goldman Sachs's XYL Position: Q1 2026 in Review

Goldman Sachs increased its Xylem (XYL) stake by 3.5% in Q1 2026, buying an estimated $8.54M and bringing the position to 1,942,649 shares worth $232M. The position accounts for 0.03% of the portfolio, ranked #612.

Goldman Sachs first reported a position in XYL in Q2 2013 and has held it in 52 quarters since. The position peaked at $327M in Q4 2016. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Goldman Sachs held 1,942,649 shares of Xylem worth $232M as of Q1 2026.
  • Goldman Sachs bought 65,098 Xylem shares in Q1 2026, an estimated $8.54M.
  • Xylem made up 0.03% of Goldman Sachs's portfolio in Q1 2026, its #612 holding.
  • Goldman Sachs first reported a position in Xylem in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Xylem position peaked at $327M in Q4 2016.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.